---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-002045"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T02:03:24.019303+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics appeals Nasdaq delisting; hearing set for June 26, 2025

## Summary
- Received Nasdaq delisting notice on May 22 for MVLS <$50M and MVPHS <$15M deficiencies.
- Requested hearing on May 28, 2025, staying delisting; hearing scheduled June 26, 2025.
- Intends to apply to transfer listing to Nasdaq Capital Market under Equity Standard requiring ≥$2.5M shareholders' equity.
- No assurance of success; securities continue trading on Nasdaq under SLXN and SLXNW.

## SEC filing metadata
- accession: 0001178913-25-002045
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/0001178913-25-002045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/zk2533312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-002045
- JSON: https://secwatch.observer/filing/0001178913-25-002045.json
- Plain text: https://secwatch.observer/filing/0001178913-25-002045.txt

## Key facts
- Listing & Compliance Notices
  Silexion Therapeutics Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C), 5810(c)(3)(C)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(A), 5450(b)(2)(C), 5810(c)(3)(C)
  source text: Listing Rules 5450(b)(2)(A) and 5450(b)(2)(C), which require a company such as ours whose securities are listed on the Nasdaq Global Market under the “Market Value Standard” to maintain a minimum Market Value of Listed Securities (an “ MVLS ”) of $50,000,000 and a minimum Market Value of Publicly Held Shares (an “ MVPHS ”) of $15,000,000 for continued listing on the Nasdaq Global Market.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/0001178913-25-002045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.